Royal Bank of Canada’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-366
| Closed | – | – | 6988 |
|
|
2024
Q2 | $0 | Sell |
366
-167
| -31% | – | ﹤0.01% | 7075 |
|
|
2024
Q1 | $1K | Buy |
533
+65
| +14% | +$122 | ﹤0.01% | 6430 |
|
|
2023
Q4 | $0 | Buy |
468
+118
| +34% | – | ﹤0.01% | 7011 |
|
|
2023
Q3 | $1K | Sell |
350
-1,227
| -78% | -$3.51K | ﹤0.01% | 6461 |
|
|
2023
Q2 | $4K | Buy |
1,577
+846
| +116% | +$2.15K | ﹤0.01% | 6294 |
|
|
2023
Q1 | $2K | Buy |
+731
| New | +$2K | ﹤0.01% | 6419 |
|
|
2022
Q2 | – | Sell |
-470
| Closed | -$3K | – | 7175 |
|
|
2022
Q1 | $3K | Sell |
470
-1,115
| -70% | -$7.12K | ﹤0.01% | 6922 |
|
|
2021
Q4 | $25K | Buy |
+1,585
| New | +$25K | ﹤0.01% | 6167 |
|